[Evaluation of neoadjuvant combination chemotherapy with pirarubicin, carmofur and tamoxifen citrate on outpatients with advanced and recurrence breast cancer]

Gan To Kagaku Ryoho. 1994 Feb;21(2):273-5.
[Article in Japanese]
No abstract available

MeSH terms

  • Aged
  • Ambulatory Care
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Outpatients
  • Tamoxifen / administration & dosage
  • Treatment Outcome

Substances

  • Tamoxifen
  • Doxorubicin
  • pirarubicin
  • carmofur
  • Fluorouracil